Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-02-21
1980-03-11
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 232303, A61K 4300, G21H 502
Patent
active
041928580
ABSTRACT:
The chloramine T procedure is employed to provide radioiodinated T.sub.3 and radioiodinated T.sub.4 from T.sub.3 and T.sub.4, respectively, at specified pHs and mole ratios to provide for long shelf life. T.sub.3 is also radioiodinated to high specific activity radioiodinated T.sub.4, and purified after a specified waiting period to remove radioactive non-antigenic contaminants and thereby provide a long shelf life.
REFERENCES:
Weeke et al., Scand. J. Clin. Lab. Invest., 32, 357 (1973).
Hallaba et al., J. Nucl. Med., 15, 270 (1970).
Burger et al., Endocrinology, 94, 1189 (1974).
Kjeld et al., Clin. Chem. Acta., 61, 381 (1971).
Thurlow et al., Ann. Clin. Biochem., 13, 364 (1976).
Mayberry et al., J. Biol. Chem., 245, 697 (1970).
Dobas et al., J. Chem. Soc. Perkin A, (1972), 1189.
Gleason, J. Biol. Chem., 213, 837 (1955).
Latham et al., J. Biol. Chem., 251, 7388 (1976).
Jiang et al., J. Am. Chem. Soc., 97, 6551 (1975).
Hales Richard H.
Reese Max G.
Becton Dickinson and Company
Marn Louis E.
Nucker Christine M.
Olstein Elliot M.
Padgett Benjamin R.
LandOfFree
Production of radioiodinated T.sub.3 and T.sub.4 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production of radioiodinated T.sub.3 and T.sub.4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of radioiodinated T.sub.3 and T.sub.4 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2000929